• Publications
  • Influence
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
PURPOSE To provide recommendations for the use of immunosuppressive drugs in the treatment of patients with ocular inflammatory disorders. PARTICIPANTS A 12-person panel of physicians withExpand
  • 767
  • 45
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
OBJECTIVE To evaluate the safety and efficacy of dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan, Inc., Irvine, CA) compared with sham in eyes with vision loss due to macular edemaExpand
  • 830
  • 45
  • PDF
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
PURPOSE To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the treatment of patients with diabetic macular edema (DME). DESIGN TwoExpand
  • 644
  • 33
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
OBJECTIVE To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal implant (DEX implant) over 12 months in eyes with macular edema owing to branch or central retinalExpand
  • 555
  • 25
  • PDF
Uveitis: Fundamentals and Clinical Practice
This new edition expands on the diagnostic and therapeutic approaches to uveitis. New fluorescein angiograms and indocyanine angiograms are presented, and descriptive case studies provide examplesExpand
  • 570
  • 22
DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS
Purpose: To evaluate the safety and efficacy of Ozurdex (dexamethasone intravitreal implant) 0.7 mg in the treatment of diabetic macular edema in vitrectomized eyes. Methods: This was a prospective,Expand
  • 292
  • 19
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.
OBJECTIVE To evaluate the safety and efficacy of a dexamethasone intravitreous drug delivery system (DDS) in eyes with diabetic macular edema (DME). METHODS Patients with persistent macular edemaExpand
  • 264
  • 15
Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
BACKGROUND Diagnosis of primary central nervous system lymphoma (PCNSL) is usually made by identifying malignant lymphocytes in the brain, cerebrospinal fluid (CSF), or vitreous. However, these cellsExpand
  • 167
  • 13
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.
OBJECTIVE To evaluate a dexamethasone intravitreous drug delivery system (DDS) in patients with persistent (> or =90 days despite treatment) macular edema. METHODS This 6-month study randomized 315Expand
  • 393
  • 12
Intraocular lymphoma. Clinical and histopathologic diagnosis.
BACKGROUND Intraocular lymphoma is associated with significant morbidity and mortality, but early diagnosis and treatment may improve prognosis. METHODS The diagnostic features of 12 cases ofExpand
  • 277
  • 12
...
1
2
3
4
5
...